Global Regenerative Artificial Skin Market Size, Share & Trends Analysis Report, By Material Type (Temporary Skin Material, Permanent Skin Material, and Composite Skin Material), By End-User (Hospitals, Wound Care Centers, and Others), Forecast (2022-2028)

The global regenerative artificial skin market is anticipated to grow at a CAGR of 6.5% during the forecast period (2022-2028). Artificial skin refers is a collagen scaffold that induces regeneration of skin in mammals such as humans. It is typically grown under in vitro conditions and can be used as skin replacement for people who have suffered burn injuries, skin diseases, or skin trauma. Such skin is usually prepared from collagen, which is easily resorbed by the body and facilitates generation of new skin on the affected area. Reconstituted human epidermis, one artificial skin type, can be cultured as submerged epidermal equivalents. Such benefits offered by the regenerative artificial skin procedure is likely to augment the market growth during the forecast period.

The market growth is also attributable to the growing demand for surgical procedures to restore skin on account of the incidence of accidental skin burns. For instance, as per the American Burn Association, 486,000 people received medical treatment for minor burns and 70,000 people were hospitalized for severe skin burn requiring acute care in the US, in 2015. Skin burns are broadly classified into three levels, namely 1st, 2nd, and 3rd degree burns. In third degree of burns where there is little or no intact skin, artificial skin graft is the most useful treatment option. Artificial skin covers and protects the wound and also promotes regeneration of natural skin. Such substantial burn related injuries are anticipated to augment the demand for surgical procedures using regenerative artificial skin, thereby driving the global regenerative artificial skin market.

Some key players operating in the market include Integra Life Sciences Corp., Smith & Nephew plc, and Organogenesis Holdings Inc., among others. The market players are focusing on several strategies such as mergers and acquisitions, partnerships, product launches, and collaborations, to increase their market share. For instance, in March 2019, Smith & Nephew plc declared that it has agreed to pay $660 million to acquire Osiris Therapeutics to enhance its presence in the regenerative medicine market. The addition of the Osiris Therapeutics will augment Smith & Nephew’s advanced wound management unit.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Material Type
• By End-User

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Integra Life Sciences Corp., Smith & Nephew plc, and Organogenesis Holdings Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Regenerative Artificial Skin Market Report by Segment

By Material Type

• Temporary Skin Material
• Permanent Skin Material
• Composite Skin Material

By End-User

• Hospitals
• Wound Care Centers
• Others

Global Regenerative Artificial Skin Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa